References

EASL clinical practice guidelines on the management of hepatocellular carcinoma

10.1016/j.jhep.2024.08.028 · 2025 · External reference

CIRSE standards of practice on thermal ablation of liver tumours

10.1007/s00270-020-02471-z · 2020 · External reference

Radiation segmentectomy for early hepatocellular carcinoma is curative

10.1016/j.jhep.2025.01.005 · 2025 · External reference

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations

10.1097/01.rvi.0000233785.75257.9a · 2006 · External reference

BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update

10.1016/j.jhep.2025.10.020 · 2026 · External reference

Locoregional therapy protocols with and without radioembolization for hepatocellular carcinoma as bridge to liver transplantation

10.1097/coc.0000000000000678 · 2020 · External reference

The segments of the hepatic veins-is there a spatial correlation to the couinaud liver segments?

10.1016/j.ejrad.2004.02.003 · 2005 · External reference

Radiation segmentectomy

10.1055/s-0041-1735529 · 2021 · External reference

Increasing yttrium-90 dose conformality using proximal radioembolization enabled by distal angiosomal truncation for the treatment of hepatic malignancy

10.1016/j.jvir.2019.12.017 · 2020 · External reference

Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery

10.21037/hbsn-22-184 · 2023 · External reference

Same-day Y90 radioembolization: implementing a new treatment paradigm

10.1007/s00259-016-3438-x · 2016 · External reference

DOORwaY90: selective internal radiation therapy using SIR-Spheres Y-90 resin microspheres as first-line treatment for unresectable hepatocellular carcinoma patients—an interim analysis

10.1007/s00270-025-04245-x · 2026 · External reference

Radiation segmentectomy for hepatocellular carcinoma

10.3390/curroncol31020045 · 2024 · External reference

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

10.1016/s2468-1253(20)30290-9 · 2021 · External reference

Single-compartment dose prescriptions for ablative 90Y-radioembolization segmentectomy

10.3390/life13061238 · 2023 · External reference

Radioembolization for the treatment of hepatocellular carcinoma: the road to personalized dosimetry and ablative practice

10.1055/s-0041-1735571 · 2021 · External reference

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

10.1007/s00259-021-05600-z · 2022 · External reference

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

10.1007/s00259-020-05163-5 · 2021 · External reference

Unresolved reference

1975 · External reference

MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature

10.2967/jnumed.108.056036 · 2009 · External reference

MIRD pamphlet no. 28, part 1: MIRDcalc-a software tool for medical internal radiation dosimetry

10.2967/jnumed.122.264225 · 2023 · External reference

MIRD pamphlet no. 29: MIRDy90-a 90Y research microsphere dosimetry tool

10.2967/jnumed.123.266743 · 2024 · External reference

Beyond the MAA-Y90 paradigm: the evolution of radioembolization dosimetry approaches and scout particles

10.1055/s-0041-1736660 · 2021 · External reference

A single centre intercomparison between commercial treatment planning systems for 90Y radioembolization using virtual and experimental phantoms

10.1016/j.ejmp.2023.103172 · 2023 · External reference

ICRU REPORT 96, dosimetry-guided radiopharmaceutical therapy

10.1177/14736691211060117 · 2021 · External reference

The role of lung density in the voxel-based dosimetry of 90Y-TARE evaluated with the voxel S-value (VSV) method and fast monte carlo simulation

10.3390/app14031019 · 2024 · External reference

The physics of radioembolization

10.1186/s40658-018-0221-z · 2018 · External reference

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct monte carlo methods

10.2967/jnumed.112.105825 · 2013 · External reference

Radiation segmentectomy or ablative external beam radiation therapy as initial treatment for solitary hepatocellular carcinoma: a multicenter experience

10.2147/jhc.s507267 · 2025 · External reference

Pathologic response of hepatocellular carcinoma treated with yttrium-90 glass microsphere radiation segmentectomy prior to liver transplantation: a validation study

10.1016/j.jvir.2020.12.019 · 2021 · External reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

10.1055/s-0030-1247132 · 2010 · External reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

10.1016/j.jhep.2011.12.001 · 2012 · External reference

Radiation treatment response assessment version 2024: category redistribution and short-term outcomes in patients undergoing 90Y radioembolization for HCC

10.2214/ajr.25.32745 · 2025 · External reference

Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology pathology correlation and survival of radiation segmentectomy

10.1002/hep.27057 · 2014 · External reference

Yttrium-90 radioembolization for the treatment of solitary, unresectable hepatocellular carcinoma: the LEGACY study

10.1002/hep.31819 · 2021 · External reference

Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER) a single-centre, single-arm study

10.1016/s2468-1253(22)00091-7 · 2022 · External reference

Efficacy and safety of radiation segmentectomy with 90Y resin microspheres for hepatocellular carcinoma

10.1148/radiol.231386 · 2024 · External reference

Segmental yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study

10.1016/j.jvir.2017.02.018 · 2017 · External reference

Evaluation of medium-term efficacy of Y90 radiation segmentectomy vs percutaneous microwave ablation in patients with solitary surgically unresectable < 4 cm hepatocellular carcinoma: a propensity score matched study

10.1007/s00270-020-02712-1 · 2021 · External reference

Radiation segmentectomy for the treatment of solitary hepatocellular carcinoma: outcomes compared with those of surgical resection

10.1016/j.jvir.2022.03.021 · 2022 · External reference

Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization

10.1016/j.ijrobp.2009.10.062 · 2011 · External reference

Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma

10.1148/radiol.2018171768 · 2018 · External reference

Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants

10.1007/s00259-020-04976-8 · 2021 · External reference

Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US multicenter HCC transplant consortium

10.1097/sla.0000000000003253 · 2020 · External reference

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

10.1111/j.1600-6143.2009.02695.x · 2009 · External reference

Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review

10.1016/j.jvir.2009.05.030 · 2009 · External reference

Complications related to transarterial treatment of hepatocellular carcinoma: a comprehensive review

10.3348/kjr.2022.0395 · 2023 · External reference

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience

10.1002/hep.29691 · 2018 · External reference

Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization

10.1016/j.cgh.2013.04.028 · 2013 · External reference

The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma

10.1097/lvt.0000000000000589 · 2025 · External reference

Downstaging outcomes for hepatocellular carcinoma: results from the multicenter evaluation of reduction in tumor size before liver transplantation (MERITS-LT) consortium

10.1053/j.gastro.2021.07.033 · 2021 · External reference

Long-term outcomes of transarterial radioembolization for large single hepatocellular carcinoma: a comparison to resection

10.2967/jnumed.121.263147 · 2022 · External reference

Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma

10.1053/j.gastro.2016.08.029 · 2016 · External reference

Radiation segmentectomy versus selective chemoembolization in the treatment of early-stage hepatocellular carcinoma

10.1016/j.jvir.2017.08.026 · 2018 · External reference

90Y radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial

10.1148/radiol.211806 · 2022 · External reference

Radiation segmentectomy versus TACE combined with microwave ablation for unresectable solitary hepatocellular carcinoma up to 3 cm: a propensity score matching study

10.1148/radiol.2016160718 · 2017 · External reference

Radiofrequency ablation therapy versus stereotactic body radiation therapy for naive hepatocellular carcinoma (≤5 cm): a retrospective multicenter study

10.2147/jhc.s488138 · 2024 · External reference